Wells Fargo lowered the firm’s price target on Ibotta (IBTA) to $86 from $95 and keeps an Overweight rating on the shares. The firm says that a promising earnings result was again offset by a guide down, the third in as many public company quarters. Wells sees the first half of 2025 growth recovery amid renewed budgets, expanding demand sources and improved sales products aimed at unlocking ROI-driven budgets.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener